These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12006918)

  • 21. Hepatic lipase gene -514C/T polymorphism in the Guangxi Hei Yi Zhuang and Han populations.
    Wu J; Yin R; Lin W; Pan S; Yang D
    Lipids; 2008 Aug; 43(8):733-40. PubMed ID: 18592285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men.
    Zhang C; Lopez-Ridaura R; Rimm EB; Rifai N; Hunter DJ; Hu FB
    Am J Clin Nutr; 2005 Jun; 81(6):1429-35. PubMed ID: 15941898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint linkage and association analysis of the hepatic lipase promoter polymorphism and lipoprotein size phenotypes.
    Almasy L; Rainwater DL; Cole S; Mahaney MC; Vandeberg JL; Hixson JE; Stern MP; MacCluer JW; Blangero J
    Hum Biol; 2005 Feb; 77(1):17-25. PubMed ID: 16114813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
    Shohet RV; Vega GL; Anwar A; Cigarroa JE; Grundy SM; Cohen JC
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1975-8. PubMed ID: 10446080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
    Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
    Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.
    Hokanson JE; Cheng S; Snell-Bergeon JK; Fijal BA; Grow MA; Hung C; Erlich HA; Ehrlich J; Eckel RH; Rewers M
    Diabetes; 2002 Apr; 51(4):1208-13. PubMed ID: 11916946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels.
    Liu WY; Yin RX; Zhang L; Wu DF; Htet Aung LH; Hu XJ; Cao XL; Miao L
    Alcohol; 2011 Nov; 45(7):681-7. PubMed ID: 21816559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity.
    Su Z; Zhang S; Nebert DW; Zhang L; Huang D; Hou Y; Liao L; Xiao C
    J Lipid Res; 2002 Oct; 43(10):1595-601. PubMed ID: 12364543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
    Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
    Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population.
    Inazu A; Nishimura Y; Terada Y; Mabuchi H
    J Hum Genet; 2001; 46(4):172-7. PubMed ID: 11322655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment.
    Lahoz C; Peña R; Mostaza JM; Laguna F; García-Iglesias MF; Taboada M; Pintó X;
    Atherosclerosis; 2005 Sep; 182(1):129-34. PubMed ID: 16115483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.
    Wang XL; Oosterhof J; Duarte N
    Cardiovasc Res; 1999 Dec; 44(3):588-94. PubMed ID: 10690291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study.
    Chen W; Srinivasan SR; Boerwinkle E; Berenson GS;
    Atherosclerosis; 2003 Jul; 169(1):175-82. PubMed ID: 12860265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM; Cupples LA; Corella D; Otvos JD; Osgood D; Martinez A; Lahoz C; Coltell O; Wilson PW; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1323-9. PubMed ID: 10807749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial lipase genetic polymorphisms and the lipid-lowering response in patients with coronary artery disease on rosuvastatin.
    Cai G; Zhang B; Shi G; Weng W; Yang L; Xue S
    Lipids Health Dis; 2016 Sep; 15(1):148. PubMed ID: 27600285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
    Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI;
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
    Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
    Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.
    Skogsberg J; McMahon AD; Karpe F; Hamsten A; Packard CJ; Ehrenborg E;
    J Intern Med; 2003 Dec; 254(6):597-604. PubMed ID: 14641801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
    Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
    Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.